Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Thrombocytosis D013922 4 associated lipids
Toxemia D014115 3 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Klebsiella Infections D007710 7 associated lipids
Ascites D001201 25 associated lipids
Albuminuria D000419 18 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Hyperinsulinism D006946 27 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Parkinson Disease D010300 53 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Bronchial Diseases D001982 3 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Tangier Disease D013631 8 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Zhu X et al. A surrogate method for assessment of beta(2)-integrin-dependent adhesion of human eosinophils to ICAM-1. 2000 J. Immunol. Methods pmid:10854610
Caslake MJ et al. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. 2000 Atherosclerosis pmid:10856534
Nakajima T et al. Phospholipase A2-mediated superoxide production of murine peritoneal macrophages induced by chrysotile stimulation. 2000 Int. J. Biochem. Cell Biol. pmid:10856708
Lee YM et al. Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally. 2000 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:10893205
Nikbakht-Sangari M et al. The role of inflammatory mediators in the mechanism of the host immune response induced by ischemia-reperfusion injury. 2000 Immunol. Invest. pmid:10709843
Turner PJ et al. Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway. 2000 Br. J. Pharmacol. pmid:10711351
Maruoka S et al. PAF-induced RANTES production by human airway smooth muscle cells requires both p38 MAP kinase and Erk. 2000 Am. J. Respir. Crit. Care Med. pmid:10712344
McClenahan DJ et al. Role of platelet-activating factor in alveolar septal injury associated with experimentally induced pneumonic pasteurellosis in calves. 2000 Am. J. Vet. Res. pmid:10714514
Yamakawa Y et al. Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation. 2000 Ann. Surg. pmid:10714632
Takada Y et al. Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation. 2000 Transplant. Proc. pmid:10715416
Yildirim G et al. Effects of platelet-activating factor and hyperbaric oxygenation on antioxidant defense and duodenal contractility. 2000 Undersea Hyperb Med pmid:11191161
Keularts IM et al. alpha(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. 2000 J. Biol. Chem. pmid:10636873
Tong N et al. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. 2000 J. Immunol. pmid:10640747
Clavijo LC et al. Platelet-activating factor and bacteremia-induced pulmonary hypertension. 2000 J. Surg. Res. pmid:10644485
Owaki T et al. Endothelial cells potentiate phagocytic killing by macrophages via platelet-activating factor release. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10644608
Ibe BO et al. Platelet activating factor acetylhydrolase activity in lamb lungs is up-regulated in the immediate newborn period. 2000 Mol. Genet. Metab. pmid:10655157
Modschiedler K et al. Dapsone and colchicine inhibit adhesion of neutrophilic granulocytes to epidermal sections. 2000 Arch. Dermatol. Res. pmid:10664013
Martin-Chouly CA et al. Modulation of PAF production by incorporation of arachidonic acid and eicosapentaenoic acid in phospholipids of human leukemic monocyte-like cells THP-1. 2000 Prostaglandins Other Lipid Mediat. pmid:10751643
Tokumura A et al. Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis. 2000 Biofactors pmid:11237195
Tan XD et al. Platelet-activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E-cadherin. 2000 Br. J. Pharmacol. pmid:10742310
Wiese A et al. Structure-dependent effects of glucose-containing analogs of platelet activating factor (PAF) on membrane integrity. 2000 Biol. Chem. pmid:10746745
Howard KM and Olson MS The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats. 2000 J. Biol. Chem. pmid:10748027
Yamada Y et al. Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population. 2000 Atherosclerosis pmid:10781653
Smith J et al. Differences in gene density on chicken macrochromosomes and microchromosomes. 2000 Anim. Genet. pmid:10782207
Friedman E et al. Effect of hydrocortisone on platelet activating factor induced lung edema in isolated rabbit lungs. 2000 Respir Physiol pmid:10786645
Yoshimatsu Y et al. Platelet-activating factor-induced intracellular calcium waves in human uterine myometrial cells. 2000 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:11074135
Walther A et al. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia. 2000 J. Surg. Res. pmid:11027469
Ciesla DJ et al. Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. 2000 Shock pmid:11028541
De Geest B et al. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:11031226
McLarnon JG et al. Anion channels modulate store-operated calcium influx in human microglia. 2000 Cell Calcium pmid:11032781
Fraga AG et al. Synthesis and pharmacological evaluation of novel heterotricyclic acylhydrazone derivatives, designed as PAF antagonists. 2000 Eur J Pharm Sci pmid:11033071
Choi SY et al. Capsaicin inhibits platelet-activating factor-induced cytosolic Ca2+ rise and superoxide production. 2000 J. Immunol. pmid:11034409
Shibata K et al. Mediation by platelet-activating factor of 12-hydroxyeicosatetraenoic acid-induced cytosolic free calcium concentration elevation in neutrophils. 2000 Prostaglandins Other Lipid Mediat. pmid:11060901
Durán WN et al. Stimulation of NO production and of eNOS phosphorylation in the microcirculation in vivo. 2000 Microvasc. Res. pmid:10964584
Wereszczynska-Siemiatkowska U et al. Lysosomal activity of pulmonary alveolar macrophages in acute experimental pancreatitis in rats with reference to positive PAF-antagonist (BN 52021) effect. 2000 Exp. Toxicol. Pathol. pmid:10965985
Prescott SM et al. Platelet-activating factor and related lipid mediators. 2000 Annu. Rev. Biochem. pmid:10966465
Kim JD et al. Platelet activating factor acetylhydrolase decreases lung reperfusion injury. 2000 Ann. Thorac. Surg. pmid:10969656
Suzuki T et al. Thromboxane A(2)-mediated Cl(-) secretion induced by platelet-activating factor in isolated rat colon. 2000 Eur. J. Pharmacol. pmid:10988347
Kallan NC and Halcomb RL Synthesis of the ring system of phomactin D using a Suzuki macrocyclization. 2000 Org. Lett. pmid:10990428
Turner PJ et al. Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway. 2000 Br. J. Pharmacol. pmid:10991932
Gastaldello K et al. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis. 2000 Nephrol. Dial. Transplant. pmid:11007834
Wratten ML et al. Hemolipodialysis attenuates oxidative stress and removes hydrophobic toxins. 2000 Artif Organs pmid:11012537
Clark WF et al. A novel treatment for lupus nephritis: lignan precursor derived from flax. 2000 Lupus pmid:10981647
Klabunde RE and Anderson DE Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage. 2000 Eur. J. Pharmacol. pmid:10996604
Nieswandt B et al. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. 2000 Blood pmid:11001906
Guan Z et al. [Role of interleukin-6 and platelet-activating factor in delaying neutrophil apoptosis]. 2000 Wei Sheng Yan Jiu pmid:12725051
Montrucchio G et al. Role of platelet-activating factor in cardiovascular pathophysiology. 2000 Physiol. Rev. pmid:11015622
Zhu W et al. Effects of platelet activating factor antagonist (BN50739) on gut mucosal injury in acute severe pancreatitis in pigs. 2000 Chin. Med. J. pmid:11776064
Wagner F et al. Ether lipids in the cell membrane of Mycoplasma fermentans. 2000 Eur. J. Biochem. pmid:11012682
Roudebush WE and Purnell ET Platelet-activating factor content in human spermatozoa and pregnancy outcome. 2000 Fertil. Steril. pmid:10927041
Matsunaga Y et al. Regulation of lymphocyte proliferation by eosinophils via chymotrypsin-like protease activity and adhesion molecule interaction. 2000 Br. J. Pharmacol. pmid:10928955
Capasso R et al. Preventive effect of eugenol on PAF and ethanol-induced gastric mucosal damage. 2000 Fitoterapia pmid:10930724
Xu H et al. Platelet-activating factor acetylhydrolase gene mutation in Japanese children with Escherichia coli O157-associated hemolytic uremic syndrome. 2000 Am. J. Kidney Dis. pmid:10873870
Cruzado JM et al. Effect of human natural xenoantibody depletion and complement inactivation on early pig kidney function. 1999 May-Jun Exp. Nephrol. pmid:10352362
Wang Y et al. Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia. 1999 May-Jun J. Soc. Gynecol. Investig. pmid:10376269
Foitzik T et al. Therapy for microcirculatory disorders in severe acute pancreatitis: effectiveness of platelet-activating factor receptor blockade vs. endothelin receptor blockade. 1999 May-Jun J. Gastrointest. Surg. pmid:10481117
Klettke U et al. Platelet-activating factor inhibits ciliary beat frequency of human bronchial epithelial cells. 1999 Mar-Apr Allergy Asthma Proc pmid:10209689
Poveshchenko AF and Kozlov VA [The effect of platelet-activating factor and its antagonist--BN 52021--on immune reactions in vivo in mice and in vitro]. 1999 Jul-Aug Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:10852052
Hocke M et al. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease. 1999 Jul-Aug Hepatogastroenterology pmid:10521992
Cijevschi I and Cijevschi D [Ocular immunopathological characteristics and the involvement of the platelet-aggregation factor and the anti-PAF at the level of the eye]. 1999 Jan-Jun Rev Med Chir Soc Med Nat Iasi pmid:10756889
Zardini DM and Tschirhart EJ [Selective differentiation and proliferation of human eosinophils from umbilical cord blood: calcium fluxes and superoxide ion secretion]. 1999 Jan-Feb Therapie pmid:10216433
Sakaguchi T et al. Acute portal hypertension increases ileal vulnerability to platelet-activating factor in rats. 1999 J. Surg. Res. pmid:10452877
Dervenis C et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. 1999 Int. J. Pancreatol. pmid:10453421
Nikbakht-Sangari M et al. Platelet-activating factor plays a role in the mechanism of major histocompatibility complex in T lymphocytes. 1999 Immunol. Invest. pmid:10454000
Subbanagounder G et al. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086. 1999 Circ. Res. pmid:10455059
Parrish PR and Larson DF Pharmacological effect of nitroprusside on platelet aggregation. 1999 J Extra Corpor Technol pmid:10915472
Kavakli K et al. Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease. 1999 Thromb. Haemost. pmid:10235463
Mariano F et al. Production of platelet-activating factor in patients with sepsis-associated acute renal failure. 1999 Nephrol. Dial. Transplant. pmid:10344354
Snyder F The ether lipid trail: a historical perspective. 1999 Biochim. Biophys. Acta pmid:9989259
Alvi SA et al. Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. 1999 Mol. Hum. Reprod. pmid:10338371
Aliberti JC et al. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. 1999 Infect. Immun. pmid:10338485
Yoshimura T et al. Estrogen replacement therapy decreases platelet-activating factor-acetylhydrolase activity in post-menopausal women. 1999 Maturitas pmid:10340285
McNulty CA et al. Characterization of the integrin and activation steps mediating human eosinophil and neutrophil adhesion to chronically inflamed airway endothelium. 1999 Am. J. Respir. Cell Mol. Biol. pmid:10340944
Yu R et al. Studies on the callus cultures of Ginkgo biloba and its metabolites-ginkgolides. 1999 Chin. J. Biotechnol. pmid:10668135
Nasu K et al. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. 1999 Mol. Hum. Reprod. pmid:10341002
Gelbard HA Neuroprotective strategies for HIV-1-associated neurologic disease. 1999 Ann. N. Y. Acad. Sci. pmid:10668436
Rainsford KD Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice. 1999 J. Pharm. Pharmacol. pmid:10344635
Callea L et al. Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis. 1999 J. Neuroimmunol. pmid:10376955
McNeil RS et al. Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue. 1999 Cell Motil. Cytoskeleton pmid:10379835
Tamaoki J et al. Effect of azelastine on platelet-activating factor-induced microvascular leakage in rat airways. 1999 Am. J. Physiol. pmid:9950898
Hayani KC et al. Impaired phagocyte oxidative capacity in human immunodeficiency virus-infected children. 1999 J. Infect. Dis. pmid:9952364
Falk S et al. Quinolines attenuate PAF-induced pulmonary pressor responses and edema formation. 1999 Am. J. Respir. Crit. Care Med. pmid:10556149
Lauener RW et al. A role for phosphatidylinositol 3-kinase in platelet aggregation in response to low, but not high, concentrations of PAF or thrombin. 1999 Biochim. Biophys. Acta pmid:10559473
Fuentes E et al. Lysophospholipids trigger calcium signals but not DNA synthesis in cortical astrocytes. 1999 Glia pmid:10559786
Ozaki N et al. Mechanosensitive properties of gastric vagal afferent fibers in the rat. 1999 J. Neurophysiol. pmid:10561400
Berger A et al. Dioleylphosphatidylglycerol inhibits the expression of type II phospholipase A2 in macrophages. 1999 Am. J. Respir. Crit. Care Med. pmid:9927381
Flickinger BD and Olson MS Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. 1999 Am. J. Pathol. pmid:10329588
Mori N et al. Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice. 1999 Am. J. Physiol. pmid:10330250
Denizot Y et al. Are lipid mediators implicated in the production of pro- and anti-inflammatory cytokines during cardiopulmonary bypass graft with extracorporeal circulation? 1999 Cytokine pmid:10328869
Held HD et al. Characterization of airway and vascular responses in murine lungs. 1999 Br. J. Pharmacol. pmid:10205008
Hüseyinov A et al. Increased gastric production of platelet-activating factor, leukotriene-B4, and tumor necrosis factor-alpha in children with Helicobacter pylori infection. 1999 Dig. Dis. Sci. pmid:10219821
Bussolati B et al. Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change. 1999 Am. J. Pathol. pmid:10027419
Kim KA et al. Pinusolide from the leaves of Biota orientalis as potent platelet activating factor antagonist. 1999 Planta Med. pmid:10083843
Karasawa K et al. Purification and characterization from rat kidney membranes of a novel platelet-activating factor (PAF)-dependent transacetylase that catalyzes the hydrolysis of PAF, formation of PAF analogs, and C2-ceramide. 1999 J. Biol. Chem. pmid:10085103
Zallen G et al. Postinjury suppression of human neutrophil cytokine production results from the stabilization of inhibitory kappaB. 1999 Shock pmid:10030791
Miyao Y et al. Role of cytokines and adhesion molecules in ischemia and reperfusion in patients with acute myocardial infarction. 1999 Jpn. Circ. J. pmid:10943615
Kaminski JJ et al. Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine. 1999 Bioorg. Med. Chem. pmid:10465415
Conroy DM and Sirois P Early bronchial hyperresponsiveness following injection of sephadex beads in the guinea pig: involvement of platelet activating factor and thromboxane A2. 1999 Inflammation pmid:10466580
Ho YS et al. Probing the substrate specificity of the intracellular brain platelet-activating factor acetylhydrolase. 1999 Protein Eng. pmid:10469831
Denham W and Norman J The potential role of therapeutic cytokine manipulation in acute pancreatitis. 1999 Surg. Clin. North Am. pmid:10470326